Where can I find 6569.TWO's financial statements?

Onyx Healthcare Inc. (6569.TWO)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for 6569.TWO?

Onyx Healthcare Inc. (6569.TWO) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does 6569.TWO update its statements?

Onyx Healthcare Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

6569.TWO

Onyx Healthcare Inc.

TWO·Medical, Healthcare Information Services · Healthcare

NT$91.80NT$0.50+0.55%

Market capNT$3.59B·Aug 26 5:30 AM UTC

TWD · values shown as reported

Line item	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	Trend
Revenue	NT$1.20B−10.8%	NT$1.60B+33.2%	NT$1.49B−6.7%	NT$1.24B−16.9%	NT$1.31B+5.8%
Cost of revenue	NT$838.03M−5.1%	NT$1.13B+34.6%	NT$936.72M−17.0%	NT$784.98M−16.2%	NT$879.27M+12.0%
Gross profit	NT$363.73M−21.6%	NT$472.31M+29.9%	NT$556.14M+17.8%	NT$456.28M−18.0%	NT$434.02M−4.9%
Research & development	NT$79.35M+15.6%	NT$86.67M+9.2%	NT$79.36M−8.4%	NT$118.32M+49.1%	NT$112.49M−4.9%
General & administrative	NT$69.21M−1.4%	NT$79.23M+14.5%	NT$77.32M−2.4%	NT$76.11M−1.6%	NT$83.40M+9.6%
Selling & marketing	NT$139.76M−13.7%	NT$162.36M+16.2%	NT$181.66M+11.9%	NT$171.36M−5.7%	NT$187.84M+9.6%
SG&A (combined)	NT$208.96M−10.0%	NT$241.59M+15.6%	NT$258.66M+7.1%	NT$247.47M−4.3%	NT$271.23M+9.6%
Other operating expenses	—	—	—	—	−NT$1.95M	—
Total operating expenses	NT$288.32M−4.1%	NT$328.26M+13.9%	NT$338.02M+3.0%	NT$365.79M+8.2%	NT$381.77M+4.4%
Operating income	NT$143.65M−30.1%	NT$244.24M+70.0%	NT$218.12M−10.7%	NT$90.49M−58.5%	NT$52.24M−42.3%
Interest income	NT$137.00K−79.4%	NT$981.00K+616.1%	NT$2.99M+204.3%	NT$7.36M+146.6%	NT$2.41M−67.3%
Interest expense	NT$2.63M+453.2%	NT$3.56M+35.1%	NT$3.68M+3.6%	NT$4.36M+18.3%	NT$4.68M+7.3%
Other income / (expense), net	NT$65.60M+56.4%	NT$96.64M+47.3%	NT$86.88M−10.1%	NT$117.68M+35.5%	NT$69.66M−40.8%
Income before tax	NT$140.11M−30.8%	NT$242.03M+72.7%	NT$305.00M+26.0%	NT$206.41M−32.3%	NT$121.91M−40.9%
Income tax expense	NT$13.60M−63.9%	NT$38.90M+185.9%	NT$49.83M+28.1%	NT$26.28M−47.3%	NT$10.21M−61.2%
Net income	NT$127.55M−23.7%	NT$202.96M+59.1%	NT$255.26M+25.8%	NT$180.91M−29.1%	NT$111.70M−38.3%

EPS (basic)	NT$3.67−22.6%	NT$5.43+48.0%	NT$6.66+22.7%	NT$4.69−29.6%	NT$2.88−38.6%
EPS (diluted)	NT$3.65−22.5%	NT$5.39+47.7%	NT$6.60+22.4%	NT$4.65−29.5%	NT$2.88−38.1%
Weighted avg shares (basic)	34,333,762	37,397,099	38,327,628	38,571,000	38,785,000
Weighted avg shares (diluted)	34,476,349	37,627,080	38,693,039	38,934,000	38,785,000

Depreciation & amortization	NT$27.04M−10.6%	NT$26.83M−0.8%	NT$24.10M−10.2%	NT$20.70M−14.1%	NT$21.81M+5.3%
EBITDA	NT$170.68M−27.6%	NT$271.07M+58.8%	NT$332.78M+22.8%	NT$164.37M−50.6%	NT$74.05M−54.9%

Frequently Asked Questions About 6569.TWO

Where can I find 6569.TWO's financial statements?: Onyx Healthcare Inc. (6569.TWO)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for 6569.TWO?: Onyx Healthcare Inc. (6569.TWO) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does 6569.TWO update its statements?: Onyx Healthcare Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

Line item

FY 2021

FY 2022

FY 2023

FY 2024

FY 2025

Trend

Revenue

NT$1.20B−10.8%

NT$1.60B+33.2%

NT$1.49B−6.7%

NT$1.24B−16.9%

NT$1.31B+5.8%

Cost of revenue

NT$838.03M−5.1%

NT$1.13B+34.6%

NT$936.72M−17.0%

NT$784.98M−16.2%

NT$879.27M+12.0%

Gross profit

NT$363.73M−21.6%

NT$472.31M+29.9%

NT$556.14M+17.8%

NT$456.28M−18.0%

NT$434.02M−4.9%

Research & development

NT$79.35M+15.6%

NT$86.67M+9.2%

NT$79.36M−8.4%

NT$118.32M+49.1%

NT$112.49M−4.9%

General & administrative

NT$69.21M−1.4%

NT$79.23M+14.5%

NT$77.32M−2.4%

NT$76.11M−1.6%

NT$83.40M+9.6%

Selling & marketing

NT$139.76M−13.7%

NT$162.36M+16.2%

NT$181.66M+11.9%

NT$171.36M−5.7%

NT$187.84M+9.6%

SG&A (combined)

NT$208.96M−10.0%

NT$241.59M+15.6%

NT$258.66M+7.1%

NT$247.47M−4.3%

NT$271.23M+9.6%

Other operating expenses

—

−NT$1.95M

—

Total operating expenses

NT$288.32M−4.1%

NT$328.26M+13.9%

NT$338.02M+3.0%

NT$365.79M+8.2%

NT$381.77M+4.4%

Operating income

NT$143.65M−30.1%

NT$244.24M+70.0%

NT$218.12M−10.7%

NT$90.49M−58.5%

NT$52.24M−42.3%

Interest income

NT$137.00K−79.4%

NT$981.00K+616.1%

NT$2.99M+204.3%

NT$7.36M+146.6%

NT$2.41M−67.3%

Interest expense

NT$2.63M+453.2%

NT$3.56M+35.1%

NT$3.68M+3.6%

NT$4.36M+18.3%

NT$4.68M+7.3%

Other income / (expense), net

NT$65.60M+56.4%

NT$96.64M+47.3%

NT$86.88M−10.1%

NT$117.68M+35.5%

NT$69.66M−40.8%

Income before tax

NT$140.11M−30.8%

NT$242.03M+72.7%

NT$305.00M+26.0%

NT$206.41M−32.3%

NT$121.91M−40.9%

Income tax expense

NT$13.60M−63.9%

NT$38.90M+185.9%

NT$49.83M+28.1%

NT$26.28M−47.3%

NT$10.21M−61.2%

Net income

NT$127.55M−23.7%

NT$202.96M+59.1%

NT$255.26M+25.8%

NT$180.91M−29.1%

NT$111.70M−38.3%

EPS (basic)

NT$3.67−22.6%

NT$5.43+48.0%

NT$6.66+22.7%

NT$4.69−29.6%

NT$2.88−38.6%

EPS (diluted)

NT$3.65−22.5%

NT$5.39+47.7%

NT$6.60+22.4%

NT$4.65−29.5%

NT$2.88−38.1%

Weighted avg shares (basic)

34,333,762

37,397,099

38,327,628

38,571,000

38,785,000

Weighted avg shares (diluted)

34,476,349

37,627,080

38,693,039

38,934,000

38,785,000

Depreciation & amortization

NT$27.04M−10.6%

NT$26.83M−0.8%

NT$24.10M−10.2%

NT$20.70M−14.1%

NT$21.81M+5.3%

EBITDA

NT$170.68M−27.6%

NT$271.07M+58.8%

NT$332.78M+22.8%

NT$164.37M−50.6%

NT$74.05M−54.9%